<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03923829</url>
  </required_header>
  <id_info>
    <org_study_id>6653486</org_study_id>
    <nct_id>NCT03923829</nct_id>
  </id_info>
  <brief_title>The Effect of Zinc on the Gingival Crevicular Fluid Level of Total Oxidant Capacity in Type 2 Diabetic Patients</brief_title>
  <official_title>The Effect of Systemic Administration of Zinc on the Gingival Crevicular Fluid Level of Total Oxidant Capacity in Type 2 Diabetic Patients With Stage II and III Periodontitis After Non-surgical Periodontal Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of systemic administration of zinc on the gingival crevicular fluid
      level of total oxidant capacity in controlled Type-2 diabetic patients with stage-II and III
      periodontitis after non-surgical periodontal therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypozincaemia and hyperzincuria is known to be present in patients with type-2 diabetes, and
      Zinc supplementation is known to be helpful in restoring plasma Zinc levels to normal,Zinc's
      deficiency can lead to an increase in circulating glucose due to beta cells malfunctioning
      and resistance to insulin, which makes it easier for type 2 diabetes mellitus (DM2) to happen
      ,Zinc was found to be a structural part of key anti-oxidant enzymes such as superoxide
      dismutase (SOD), and Zinc deficiency impaired their synthesis, leading to increased oxidative
      stress
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2019</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The outcome assessor and statistician will be blinded to the intervention</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline Hb-A1c</measure>
    <time_frame>change from baseline Hb-A1c at 3 monthes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hb-A1c</measure>
    <time_frame>at the baseline and after 3 months</time_frame>
    <description>Hb-A1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing pocket depth</measure>
    <time_frame>at the baseline and after 3 months</time_frame>
    <description>Probing pocket depth Measured as the distance between the gingival margin and the apical part of the pocket will be measured using William's graduated periodontal probe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level</measure>
    <time_frame>at the baseline and after 3 months</time_frame>
    <description>It will be measured from the cemento-enamel junction till the apical part of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival index</measure>
    <time_frame>at the baseline and after 3 months</time_frame>
    <description>Gingival Index for a specific tooth == Average (points for the 4 surfaces)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Zinc administration with scaling and root planing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>systemic administration of Zinc cap of 50 mg elemental zinc as zinc sulphate, once a day for 12 weeks in addition to scaling and root planing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scaling and root planing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>scaling and root planing</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zinc Sulfate</intervention_name>
    <description>systemic administration of Zinc sulfate with scaling and root planing</description>
    <arm_group_label>Zinc administration with scaling and root planing</arm_group_label>
    <other_name>Zinc Sulfate with scaling and root planing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>scaling and root planing</intervention_name>
    <description>scaling and root planing</description>
    <arm_group_label>scaling and root planing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Controlled Type-2 diabetes mellitus

          -  Stage-II &amp;III periodontitis

          -  At least 2 sites with clinical attachment loss 3 or 4 mm to ≥5 mm and radiographic
             bone loss 15% Extending to mid-third of root and beyond.

          -  Probing depth from ≤5 mm to ≥6 mm

        Exclusion Criteria:

          -  Any periodontal or Antibiotic treatment during the last six months.

          -  Receiving trace element supplements in the previous three months

          -  Pregnant or lactating females

          -  Gastric or diuretic treatment

          -  Acute renal failure

          -  smoking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Enji Ahmed, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. weam elbattawy, Lecturer</last_name>
    <role>Study Director</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr. Ollfat Shaker, professor</last_name>
    <role>Study Director</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>abdulrahman A Abdulrab</last_name>
    <phone>+201014624724</phone>
    <email>abdulrahman.awadh@dentistry.cu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dr. Enji Ahmed, professor</last_name>
    <phone>+201018941119</phone>
    <email>enji.ahmed@dentistry.cu.edu.eg</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Khan MI, Siddique KU, Ashfaq F, Ali W, Reddy HD, Mishra A. Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients. J Nat Sci Biol Med. 2013 Jul;4(2):336-40. doi: 10.4103/0976-9668.117002.</citation>
    <PMID>24082728</PMID>
  </results_reference>
  <results_reference>
    <citation>Thomas B, Prasad RB, Shetty S, Vishakh R. Comparative Evaluation of the Lipid Profile in the Serum of Patients with Type II Diabetes Mellitus and Healthy Individuals with Periodontitis. Contemp Clin Dent. 2017 Jan-Mar;8(1):96-101. doi: 10.4103/ccd.ccd_1160_16.</citation>
    <PMID>28566858</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>April 22, 2019</last_update_submitted>
  <last_update_submitted_qc>April 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Abdulrahman Abdulqawi Awadh Abdulrab</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>zinc</keyword>
  <keyword>Non-surgical Periodontal Therapy</keyword>
  <keyword>stage II periodontitis</keyword>
  <keyword>stage III periodontitis</keyword>
  <keyword>gingival crevicular fluid</keyword>
  <keyword>total oxidant capacity</keyword>
  <keyword>Type 2 diabetic patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Zinc Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

